Is PFE Stock a Buy After 14% Rise Post Drug Pricing Deal With Trump?
Key Takeaways Pfizer struck a deal with Trump to cut drug prices and expand U.S. innovation and manufacturing.The company committed $70B in U.S. investments, gaining a three-year tariff exemption in return.PFE shares jumped nearly 14% as the agreement eased major concerns for the pharma industry.Pfizer (PFE) recently announced a landmark deal with the Trump administration. Per the deal, Pfizer committed to key measures aimed at lowering prescription drug costs while boosting investment in U.S.-based innovat ...